Abstract
Experiments were performed to study the effects of inorganic arsenic (iAs) on liver and kidney functions of diabetic rats. Data showed that arsenic concentration decreases in the liver and kidneys of rats in hyperglycemic conditions. Alanine aminotransferase (ALT) activity was markedly less in arsenic-diabetic rats compared to arsenic alone; however, hyperbilirubinemia was observed in arsenic-diabetic animals. Creatinine values showed improved kidney function in arsenic-diabetic rats compared to arsenic alone. Histopathological observations were less severe in inorganic arsenic liver and kidneys of alloxan-diabetic rats. These observations were considered to be important since they partially argue against earlier reports that demonstrated a diabetogenic effect attributed to arsenic.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
